Page 6 of 8

BI3.1-6 | Chemistry and Metabolism of Carbohydrates — Glossary

Carbohydrate
Polyhydroxy aldehydes or ketones, classified as monosaccharides, disaccharides, or polysaccharides, serving as energy fuel, structural elements, and storage molecules
Glycolysis
The universal 10-step cytoplasmic pathway that converts one glucose molecule to two pyruvate molecules, yielding 2 ATP and 2 NADH net
PFK-1 (Phosphofructokinase-1)
The rate-limiting enzyme of glycolysis that converts F6P to F1,6-BP; activated by AMP and F2,6-BP, inhibited by ATP and citrate
TCA cycle (Krebs cycle)
The final common pathway for oxidation of acetyl-CoA in the mitochondrial matrix, generating 3 NADH, 1 FADH2, and 1 GTP per turn
Pyruvate dehydrogenase complex
A multienzyme complex that irreversibly converts pyruvate to acetyl-CoA, linking glycolysis to the TCA cycle, requiring five coenzymes (TPP, lipoic acid, CoA, FAD, NAD+)
Gluconeogenesis
The synthesis of glucose from non-carbohydrate precursors (lactate, glycerol, amino acids) in the liver and kidney, costing 6 ATP equivalents per glucose
Cori cycle
The metabolic cycle where lactate produced by anaerobic glycolysis in muscle is transported to liver for gluconeogenesis, and the resulting glucose returns to muscle
Glycogenesis
The synthesis of glycogen from glucose, with glycogen synthase as the rate-limiting enzyme, stimulated by insulin
Glycogenolysis
The breakdown of glycogen to G1P by glycogen phosphorylase, stimulated by glucagon (liver) and epinephrine (muscle)
HMP shunt (Pentose Phosphate Pathway)
An alternative glucose oxidation pathway producing NADPH for reductive biosynthesis and ribose-5-phosphate for nucleotide synthesis
G6PD (Glucose-6-Phosphate Dehydrogenase)
The rate-limiting enzyme of the HMP shunt that generates NADPH; its X-linked deficiency causes haemolytic anaemia triggered by oxidant drugs and fava beans
SGLT-1
Sodium-glucose linked transporter 1 — a secondary active transporter on the intestinal brush border that co-transports glucose and galactose with Na+
GLUT-4
The insulin-dependent glucose transporter in muscle and adipose tissue, stored in intracellular vesicles and translocated to the membrane by insulin signalling
Insulin
A peptide hormone from pancreatic beta-cells that promotes glucose uptake, glycolysis, glycogenesis, and lipogenesis in the fed state
Glucagon
A peptide hormone from pancreatic alpha-cells that promotes glycogenolysis and gluconeogenesis in the fasting state to maintain blood glucose
HbA1c (Glycated Haemoglobin)
Haemoglobin non-enzymatically glycated at the N-terminal valine; reflects average blood glucose over 2-3 months, with ≥6.5% diagnostic for diabetes
Diabetic ketoacidosis (DKA)
A life-threatening complication of insulin deficiency (usually Type 1 DM) with hyperglycaemia, ketone body accumulation, and metabolic acidosis
AGEs (Advanced Glycation End-products)
Irreversible products of non-enzymatic protein glycation in chronic hyperglycaemia that cross-link proteins and activate inflammatory pathways via RAGE receptors
Polyol pathway
The pathway converting glucose to sorbitol (by aldose reductase) then fructose; causes osmotic damage in diabetic lens, nerves, and vessels
Galactosaemia
An inborn error of galactose metabolism due to galactose-1-P uridylyltransferase deficiency, causing cataracts, hepatomegaly, and intellectual disability
Lactose intolerance
Deficiency of intestinal lactase causing undigested lactose to ferment in the colon, producing bloating, cramps, and osmotic diarrhoea; affects 60-80% of Indian adults
Glycogen storage diseases
A group of inherited disorders caused by deficient enzymes of glycogen metabolism, including Von Gierke (Type I), Pompe (Type II), and McArdle (Type V)
Warburg effect
The observation that cancer cells preferentially use glycolysis even in the presence of oxygen (aerobic glycolysis), the basis for PET-FDG cancer imaging
Metabolic syndrome
A cluster of central obesity, hypertension, hyperglycaemia, hypertriglyceridaemia, and low HDL driven by insulin resistance, highly prevalent in South Asians
Fructose-2,6-bisphosphate (F2,6-BP)
The most potent allosteric activator of PFK-1 and inhibitor of fructose-1,6-bisphosphatase, serving as the master switch between glycolysis and gluconeogenesis